However, retrospective studies assessing the gene expression profiles [8], and cytogenetics [23–26] of MM patients have not reported consistent differences between IgA versus non-IgA MM subtypes to explain the difference in prognosis. The gene discussed is CD79A; the disease is Miyoshi myopathy.